Exercise in Pediatric Cancer Patients
This study is looking at whether structured exercise can help children and young adults (ages 2-25) who have been newly diagnosed with cancer and are receiving chemotherapy. It compares a special exercise program called "Just Move" (exercising five times a week) to standard care (exercising as tolerated). Researchers want to see if the "Just Move" program can help you maintain or improve your physical abilities over an 18-month period. The study is currently unclear about its recruitment status and aims to enroll 60 participants. This study is investigating how exercise might affect the immune system (IMMUNOTHERAPY) in pediatric cancer patients.
- Study design
- This is a randomized, controlled study that plans to enroll 60 participants. It compares two different exercise approaches.
- What's involved
- Participants in the "Just Move" group will complete exercises five times per week. Physical functioning will be measured using tests like the 6-Minute Walk test.
- Compensation
- Not stated in the trial record.
- Follow-up
- The potential benefits of exercise will be measured over an 18-month period.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Jennifer Pope, MD · PRINCIPAL_INVESTIGATOR · Wake Forest University Health Sciences
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Potential benefit of increasing/maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment18 month period
Investigate if 30 minutes of exercise, five days per week, will have benefit relative to the control arm by increasing and/or maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment as measured by 6-Minute Walk test
- Potential benefit of increasing/maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment18 month period
Investigate if 30 minutes of exercise, five days per week, will have benefit relative to the control arm by increasing and/or maintaining physical functioning in pediatric subjects undergoing chemotherapy and childhood cancer treatment as measured by BOT-2 Brief (in subjects ≥ 4 years of age) or PDMS-2 (in subjects \< 4 years of age).